Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia

Abstract

The majority of studies that provide insights into the influence of the microbiome on the health of hematologic malignancy patients have concentrated on the transplant setting. Here, we sought to assess the predictive capacity of the gastrointestinal microbiome and its relationship to infectious outcomes in patients with acute myeloid leukemia (AML).

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 22, 2019
Source ID
10.1093/cid/ciz777

Entities

People

  • Chelcy E Brumlow
  • Christine B Peterson
  • Dimitrios P. Kontoyiannis
  • Jennifer Wargo
  • Jessica R Galloway-peña
  • Kim-anh Do
  • Mansour Alfayez
  • Md Abdul Wadud Khan
  • Naval G Daver
  • Prajwal C Boddu
  • Pranoti Sahasrabhojane
  • Robert R Jenq
  • Samuel A Shelburne
  • Vancheswaran Gopalakrishnan
  • Yushu Shi

Organizations

  • American Association for Cancer Research
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • The University of Texas MD Anderson Cancer Center
  • United States Department of Defense
  • University of Texas at Austin
  • Yale University

Tags

Readers

  • Microbial Pathology
  • Oncology

Technology Areas

  • Biotechnology